WhaleCreep

Which hedge funds own ONCEEUR? SPARK THERAPEUTICS INC, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in ONCEEUR (SPARK THERAPEUTICS INC) in their Q2 2026 13F filings, worth $0 in total.

0
Holders
0
New this quarter
0
Exited this quarter
$0
Combined value
–
Share of managers holding

Holders, Q2 2026

0 rows

Ownership over time

By quarter
QuarterHoldersManagers filingShare holdingCombined value
Q4 20190670.0%$0
Q3 20193605.0%$309m
Q2 20194606.7%$289m
Q1 20194606.7%$237m
Q4 20183605.0%$46.8m
Q3 20183595.1%$47.8m
Q2 20182593.4%$43.0m
Q1 20182593.4%$33.4m
Q4 20172593.4%$16.0m
Q3 20175568.9%$46.0m
Q2 20172563.6%$12.9m
Q1 20171561.8%$7.2m
Q4 20161561.8%$6.4m
Q3 20161521.9%$5.6m
Q2 20162523.8%$9.5m
Q1 20161521.9%$5.0m
Q4 20152523.8%$8.5m
Q2 20150520.0%$0
Q1 20152523.8%$802k

Who discovered ONCEEUR first?

Earliest meaningful positions among the 9 tracked managers seen opening ONCEEUR since Q1 2015.

1 rows
Pentwater Capital Management LP high convictionQ2 20191.5%6.3%2Exited by Q4 2019−5.3%

Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.

1 already held it when coverage began

Casdin Capital, LLC (Q4 2015)